The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
A Randomized Controlled Trial of Risperidone, Lithium, or Divalproex Sodium for Initial Treatment of Bipolar I Disorder, Manic or Mixed Phase, in Children and Adolescents
Open accessAbstract
CONTEXT: There was a paucity of comparative pharmacological research for initial treatment of bipolar I disorder, manic or mixed phase, in children and adolescents. OBJECTIVE: To investigate which medication to administer first to antimanic medication-naive subjects. DESIGN, SETTING, AND PARTICIPANTS: The Treatment of Early Age Mania (TEAM) study recruited 6- to 15-year-old children and adolescents with DSM-IV bipolar I disorder (manic or mixed phase) at 5 US sites from 2003 to 2008 into a controlled, randomized, no-patient-choice, 8-week protocol. Blinded, independent evaluators conducted all baseline and end-point assessments. INTERVENTIONS: Subjects received a titrated schedule of lithium, divalproex sodium, or risperidone. Medications were increased weekly only if there was inadequate response, and no dose-limiting adverse effects, to maximum doses of lithium carbonate (1.1-1.3 mEq/L), divalproex sodium (111-125 μg/mL), and risperidone (4-6 mg). MAIN OUTCOME MEASURES: Primary outcome measures were the Clinical Global Impressions for Bipolar Illness Improvement-Mania and the Modified Side Effects Form for Children and Adolescents. RESULTS: There were 279 antimanic medication-naive subjects (mean [SD] age, 10.1 [2.8] years; 50.2% female) who had the following characteristics: 100% elated mood and/or grandiosity, 77.1% psychosis, 97.5% mixed mania, 99.3% daily rapid cycling, and mean (SD) mania duration of 4.9 (2.5) years. The mean (SD) titrated lithium level was 1.09 (0.34) mEq/L, and the mean (SD) divalproex sodium level was 113.6 (23.0) μg/mL. The mean (SD) titrated risperidone dose was 2.57 (1.21) mg. Higher response rates occurred with risperidone vs lithium (68.5% vs 35.6%; χ(2)(1) = 16.9, P < .001) and vs divalproex sodium (68.5% vs 24.0%; χ(2)(1) = 28.3, P < .001). Response to lithium vs divalproex sodium did not differ. The discontinuation rate was higher for lithium than for risperidone (χ(2)(1) = 6.4, P = .011). Increased weight gain, body mass index, and prolactin level occurred with risperidone vs lithium (F(1,212) = 45.5, P < .001; F(1,212) = 39.1, P < .001; and F(1,213) = 191.4, P < .001, respectively) and vs divalproex sodium (F(1,212) = 34.7, P < .001; F(1,212) = 45.3, P < .001; and F(1,213) = 209.4, P < .001, respectively). The thyrotropin level increased in subjects taking lithium (t(62) = 11.3, P < .001). CONCLUSIONS: Risperidone was more efficacious than lithium or divalproex sodium for the initial treatment of childhood mania but had potentially serious metabolic effects. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00057681
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Further, other studies have also suggested the efficacy of combination therapy (eg, risperidone plus lithium or divalproex584 and lithium plus divalproex or carbamazepine606) to achieve and maintain remission.”
From Canadian Network for Mood and Anxiety Treatments ( CANMAT ) and International Society for Bipolar Disorders ( ISBD ) 2018 guidelines for the management of patients with bipolar disorder (2018) · cites this paper as [584]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Children's Global Assessment Scale (CGAS)
Shaffer, D. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790100074010 · Cited by 3,716
Correll, C. U. (2009) · JAMA · doi:10.1001/jama.2009.1549 · Cited by 1,050
Spearing, M. K., Post, R. M., Leverich, G. S., Brandt, D., & Nolen, W. (1997) · Psychiatry Research · doi:10.1016/s0165-1781(97)00123-6 · Cited by 978
Bowden, C. L. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.5.481 · Cited by 678
Clinical Course of Children and Adolescents With Bipolar Spectrum Disorders
Birmaher, B. B., Axelson, D., Strober, M. A., Gill, M. K., Valeri, S. M., Chiappetta, L., Ryan, N. D., Leonard, H., Hunt, J., Iyengar, S., et al. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.2.175 · Cited by 664
National Trends in the Outpatient Treatment of Children and Adolescents With Antipsychotic Drugs
Olfson, M., Blanco, C., Liu, L., Moreno, C., & Laje, G. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.6.679 · Cited by 590
Aggregating Data from Multiple Informants in Child Psychiatry Epidemiological Research
Bird, H., Gould, M. S., & STAGHEZZA, B. M. (1992) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199201000-00012 · Cited by 552
Nonfasting triglycerides and risk of ischemic stroke in the general population
Freiberg, J. J. (2008) · JAMA · doi:10.1001/jama.2008.621 · Cited by 542
Geller, B., Tillman, R., Craney, J. L., & Bolhofner, K. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.5.459 · Cited by 472
Self-citationGeller, B., Zimerman, B., Williams, M., Bolhofner, K., Craney, J. L., DelBello, M. P., & Soutullo, C. A. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200104000-00014 · Cited by 456
Self-citation
Cited by
Sorted by citations
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Bond, D. J., Frey, B. N., Sharma, V., Goldstein, B. I., Rej, S., Beaulieu, S., et al. (2018) · Bipolar Disorders · doi:10.1111/bdi.12609 · Cited by 1,852
Grande, I., Berk, M., Birmaher, B., & Vieta, E. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00241-x · Cited by 1,710
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Beaulieu, S., Alda, M., O’Donovan, C., MacQUEEN, G. M., McIntyre, R. S., Sharma, V., et al. (2012) · Bipolar Disorders · doi:10.1111/bdi.12025 · Cited by 1,230
Vieta, E., Berk, M., Schulze, T. G., Carvalho, A. F., Suppes, T., Calabrese, J. R., Gao, K., Miskowiak, K. W., & Grande, I. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.8 · Cited by 891
Carvalho, A. F., Firth, J., & Vieta, E. (2020) · New England Journal of Medicine · doi:10.1056/nejmra1906193 · Cited by 562
Goldstein, B. I., Carnethon, M. R., Matthews, K. A., McIntyre, R. S., Miller, G. E., Raghuveer, G., Stoney, C. M., Wasiak, H., & McCrindle, B. W. (2015) · Circulation · doi:10.1161/cir.0000000000000229 · Cited by 519
Goldstein, B. I., Birmaher, B. B., Carlson, G. A., DelBello, M. P., Findling, R. L., Fristad, M. A., Kowatch, R. A., Miklowitz, D. J., Nery, F. G., Algorta, G. P., et al. (2017) · Bipolar Disorders · doi:10.1111/bdi.12556 · Cited by 246
Mazereel, V., Detraux, J., Vancampfort, D., van Winkel, R., & Binder, M. D. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.573479 · Cited by 233
Lithium in the Acute Treatment of Bipolar I Disorder: A Double-Blind, Placebo-Controlled Study
Findling, R. L., Robb, A. S., McNamara, N., Pavuluri, M. N., Kafantaris, V., Scheffer, R. E., Frazier, J. A., Rynn, M. A., DelBello, M. P., Kowatch, R. A., et al. (2015) · PEDIATRICS · doi:10.1542/peds.2015-0743 · Cited by 158
Yatham, L. N., Chakrabarty, T., Bond, D. J., Schaffer, A., Beaulieu, S., Parikh, S. V., McIntyre, R. S., Milev, R. V., Alda, M., Vázquez, G. H., et al. (2021) · Bipolar Disorders · doi:10.1111/bdi.13135 · Cited by 117
Correll, C. U., Olvet, D. M., Auther, A. M., Hauser, M., Kishimoto, T., Carrión, R. E., Snyder, S., & Cornblatt, B. A. (2014) · Bipolar Disorders · doi:10.1111/bdi.12209 · Cited by 106
The New News about Lithium: An Underutilized Treatment in the United States
Post, R. M. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.238 · Cited by 108
Peuskens, J., Pani, L., Detraux, J., & De Hert, M. (2014) · CNS Drugs · doi:10.1007/s40263-014-0157-3 · Cited by 350
Bipolar disorder in children and adolescents
Birmaher, B. B. (2013) · Child and Adolescent Mental Health · doi:10.1111/camh.12021 · Cited by 102
Weight Considerations in Psychotropic Drug Prescribing and Switching
Hasnain, M., & Vieweg, W. V. R. (2013) · Postgraduate Medicine · doi:10.3810/pgm.2013.09.2706 · Cited by 86
Hafeman, D. M., Rooks, B., Merranko, J., Liao, F., Gill, M. K., Goldstein, T. R., Diler, R., Ryan, N., Goldstein, B. I., Axelson, D. A., et al. (2020) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2019.06.013 · Cited by 83
Obesity in Adolescents with Psychiatric Disorders
Chao, A. M., Wadden, T. A., & Berkowitz, R. I. (2019) · Current Psychiatry Reports · doi:10.1007/s11920-019-0990-7 · Cited by 89
Post-Acute Effectiveness of Lithium in Pediatric Bipolar I Disorder
Findling, R. L., Kafantaris, V., Pavuluri, M. N., McNamara, N., Frazier, J. A., Sikich, L., Kowatch, R. A., Rowles, B. M., Clemons, T. E., & Taylor‐Zapata, P. (2013) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2012.0063 · Cited by 77
Montejo, Á. L., Arango, C., Bernardo, M., Carrasco, J. L., Crespo-Facorro, B., Cruz, J. J., Del Pino-Montes, J., García-Escudero, M. A., García-Rizo, C., González-Pinto, A., et al. (2017) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2017.02.003 · Cited by 75
Jensen, K. G., Juul, K., Fink‐Jensen, A., Correll, C. U., & Pagsberg, A. K. (2014) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2014.10.002 · Cited by 78
Martínez-Ortega, J. M., Funes-Godoy, S., Díaz-Atienza, F., Gutiérrez-Rojas, L., Pérez-Costillas, L., & Gurpegui, M. (2013) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-013-0399-5 · Cited by 72
The effect of antidepressants and antipsychotics on weight gain in children and adolescents
Reekie, J., Hosking, S. P. M., Prakash, C., Kao, K., Juonala, M., & Sabin, M. A. (2015) · Obesity Reviews · doi:10.1111/obr.12284 · Cited by 75
Treatment Moderators and Predictors of Outcome in the Treatment of Early Age Mania (TEAM) Study
Vitiello, B., Riddle, M. A., Yenokyan, G., Axelson, D., Wagner, K. D., Joshi, P. T., Walkup, J. T., Luby, J. L., Birmaher, B. B., Ryan, N. D., et al. (2012) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2012.07.001 · Cited by 71
Differentiating Bipolar Disorder–Not Otherwise Specified and Severe Mood Dysregulation
Towbin, K. E., Axelson, D., Leibenluft, E., & Birmaher, B. B. (2013) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2013.02.006 · Cited by 69
Fristad, M. A., Young, A. S., Vesco, A. T., Nader, E. S., Healy, K. Z., Gardner, W. P., Wolfson, H. L., & Arnold, L. E. (2015) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2015.0132 · Cited by 73
Gomes‐da‐Costa, S., Marx, W., Corponi, F., Anmella, G., Murru, A., Pons-Cabrera, M. T., Giménez‐Palomo, A., Gutiérrez-Arango, F., Llach, C.-D., Fico, G., et al. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.07.011 · Cited by 71
Management of Adverse Effects of Mood Stabilizers
Murru, A., Popović, D., Pacchiarotti, I., Hidalgo, D., Caballero, J. L., & Vieta, E. (2015) · Current Psychiatry Reports · doi:10.1007/s11920-015-0603-z · Cited by 63
The Significance of At-Risk or Prodromal Symptoms for Bipolar I Disorder in Children and Adolescents
Hauser, M., & Correll, C. U. (2013) · The Canadian Journal of Psychiatry · doi:10.1177/070674371305800106 · Cited by 61
Post, R. M., Altshuler, L. L., Kupka, R., McElroy, S. L., Frye, M. A., Rowe, M., Leverich, G. S., Grunze, H., Suppes, T. M., Keck, P. E., et al. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.02.006 · Cited by 60
Pisano, S., Catone, G., Veltri, S., Lanzara, V., Pozzi, M., Clementi, E., Iuliano, R., Riccio, M. P., Radice, S., Molteni, M., et al. (2016) · The Italian Journal of Pediatrics/Italian journal of pediatrics · doi:10.1186/s13052-016-0259-2 · Cited by 60
High Prevalence of Metabolic Syndrome Among Adolescents and Young Adults With Bipolar Disorder
Li, C., Birmaher, B. B., Rooks, B., Gill, M. K., Hower, H. M., Axelson, D., Dickstein, D. P., Goldstein, T. R., Liao, F., Yen, S., et al. (2019) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.18m12422 · Cited by 61
How to Understand Divergent Views on Bipolar Disorder in Youth
Carlson, G. A., & Klein, D. N. (2014) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-032813-153702 · Cited by 61
Early-Onset Bipolar Disorder: Characteristics and Outcomes in the Clinic
Connor, D. F., Ford, J. D., Pearson, G. S., Scranton, V. L., & Dusad, A. (2017) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2017.0058 · Cited by 51
Pharmacotherapy of bipolar disorder in children and adolescents: an update
Peruzzolo, T. L., Tramontina, S., Rohde, L. A., & Zeni, C. (2013) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2012-0999 · Cited by 49
Post, R. M., Altshuler, L. L., Kupka, R., McElroy, S. L., Frye, M. A., Rowe, M., Grunze, H., Suppes, T. M., Keck, P. E., Leverich, G. S., et al. (2016) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.06.008 · Cited by 50
Findling, R. L., Stepanova, E. A., Youngstrom, E. A., & Young, A. S. (2018) · Evidence-Based Mental Health · doi:10.1136/eb-2018-102912 · Cited by 48
McKnight, R. F., de Vauvert, S. J. G. N. D. L. M. D. B., Chesney, E., Amit, B. H., Geddes, J. R., & Cipriani, A. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004048.pub4 · Cited by 49
Chang, Y. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.1578 · Cited by 46
Comorbid sleep disorders and suicide risk among children and adolescents with bipolar disorder
Stanley, I. H., Hom, M. A., Luby, J. L., Joshi, P. T., Wagner, K. D., Emslie, G. J., Walkup, J. T., Axelson, D., & Joiner, T. E. (2017) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2017.07.027 · Cited by 43
Joshi, G., Petty, C. R., Wozniak, J. R., Faraone, S. V., Spencer, A. E., Woodworth, K. Y., Shelley-Abrahamson, R., McKillop, H. N., Furtak, S. L., & Biederman, J. (2013) · Psychopharmacology · doi:10.1007/s00213-013-2970-7 · Cited by 42
Pharmacologic Treatment of Bipolar Disorder in Children and Adolescents
Goldstein, B. I., Sassi, R. B., & Diler, R. S. (2012) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2012.07.004 · Cited by 43
Post, R. M., Chang, K., & Frye, M. A. (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12com08136 · Cited by 41
Depression and Suicidality Outcomes in the Treatment of Early Age Mania Study
Salpekar, J. A., Joshi, P. T., Axelson, D., Reinblatt, S. P., Yenokyan, G., Sanyal, A., Walkup, J. T., Vitiello, B., Luby, J. L., Wagner, K. D., et al. (2015) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2015.09.016 · Cited by 40
Pacchiarotti, I., Murru, A., Kotzalidis, G. D., Bonnín, C. D. M., Mazzarini, L., Colom, F., & Vieta, E. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.04.007 · Cited by 40
Possible mechanisms for the skeletal effects of antipsychotics in children and adolescents
Calarge, C. A., Ivins, S. D., Motyl, K. J., Shibli-Rahhal, A. A., Bliziotes, M. M., & Schlechte, J. (2013) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125313487548 · Cited by 39
Safety and efficacy of lithium in children and adolescents: A systematic review in bipolar illness
Amerio, A., Ossola, P., Scagnelli, F., Odone, A., Allinovi, M., Cavalli, A., Iacopelli, J., Tonna, M., Marchesi, C., & Ghaemi, S. N. (2018) · European Psychiatry · doi:10.1016/j.eurpsy.2018.07.012 · Cited by 37
Patino, L. R., Klein, C. C., Strawn, J. R., Blom, T. J., Tallman, M. J., Adler, C. M., Welge, J. A., & DelBello, M. P. (2021) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2021.0039 · Cited by 36
Jochim, J., Rifkin-Zybutz, R. P., Geddes, J. R., & Cipriani, A. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004052.pub2 · Cited by 37
Pisano, S., Pozzi, M., Catone, G., Scrinzi, G., Clementi, E., Coppola, G., Milone, A., Bravaccio, C., Santosh, P., & Masi, G. (2017) · Current Neuropharmacology · doi:10.2174/1570159x16666171219142120 · Cited by 35
Leibenluft, E., & Dickstein, D. P. (2015) · Wiley eBooks · doi:10.1002/9781118381953.ch62 · Cited by 34
Treatment of Bipolar Depression
Post, R. M. (2016) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2015.09.001 · Cited by 33
Psychopharmacology of Bipolar Disorders in Children and Adolescents
Stepanova, E. A., & Findling, R. L. (2017) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2017.08.002 · Cited by 32
Prescriber's Guide – Children and Adolescents
Stahl, S. M. (2018) · Cambridge University Press eBooks · doi:10.1017/9781108561402 · Cited by 33
Seymour, K. E., Pescosolido, M. F., Reidy, B. L., Galvan, T., Kim, K. L., Young, M. E., & Dickstein, D. P. (2013) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2013.03.011 · Cited by 33
Toward prevention of bipolar disorder in at-risk children: Potential strategies ahead of the data
Post, R. M., Goldstein, B. I., Birmaher, B., Findling, R. L., Frey, B. N., DelBello, M. P., & Miklowitz, D. J. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.03.025 · Cited by 31
Davico, C., Canavese, C., Vittorini, R., Gandione, M., & Vitiello, B. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00270 · Cited by 32
Prolactin Serum Concentrations During Aripiprazole Treatment in Youth
Safer, D. J., Calarge, C. A., & Safer, A. M. (2013) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2012.0062 · Cited by 31
Challenges and Promises of Pediatric Psychopharmacology
Giles, L. L., & Martini, D. R. (2016) · Academic Pediatrics · doi:10.1016/j.acap.2016.03.011 · Cited by 31
The Challenges of Children with Bipolar Disorder
Post, R. M., & Grunze, H. (2021) · Medicina · doi:10.3390/medicina57060601 · Cited by 32
Papolos, D. F., Teicher, M. H., & Post, R. M. (2025) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13817 · Cited by 31
Dickstein, D. P., Cushman, G. K., Kim, K. L., Weissman, A. B., & Wegbreit, E. (2015) · CNS Spectrums · doi:10.1017/s109285291500036x · Cited by 29
Duffy, A. C., Heffer, N., Goodday, S., Weir, A., Patten, S. B., Malhi, G. S., & Cipriani, A. (2018) · Bipolar Disorders · doi:10.1111/bdi.12690 · Cited by 29
Double jeopardy in the United States: Early onset bipolar disorder and treatment delay
Post, R. M., Altshuler, L. L., Kupka, R., McElroy, S. L., Frye, M. A., Rowe, M., Grunze, H., Suppes, T. M., Keck, P. E., & Nolen, W. A. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.113274 · Cited by 28
ECG parameters in children and adolescents treated with aripiprazole and risperidone
Germanò, E., Italiano, D., Lamberti, M., Guerriero, L., Privitera, C., D’Amico, G., Siracusano, R., Ingrassia, M., Spina, E., Calabrò, M. P., et al. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.10.020 · Cited by 29
Renk, K., White, R., Lauer, B.-A., McSwiggan, M., Puff, J., & Lowell, A. (2014) · Psychiatry Journal · doi:10.1155/2014/928685 · Cited by 31
Genetic Risk Score Analysis in Early-Onset Bipolar Disorder
Croarkin, P. E., Luby, J. L., Cercy, K. M., Geske, J. R., Veldić, M., Simonson, M., Joshi, P. T., Wagner, K. D., Walkup, J. T., Nassan, M. M., et al. (2017) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.15m10314 · Cited by 27
Vita, G., Nöhles, V. B., Ostuzzi, G., Barbui, C., Tedeschi, F., Heuer, F. H., Keller, A., DelBello, M. P., Welge, J. A., Blom, T. J., et al. (2024) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2024.07.920 · Cited by 29
The Comorbidity of ADHD and Bipolar Disorder: Any Less Confusion?
Pataki, C. S., & Carlson, G. A. (2013) · Current Psychiatry Reports · doi:10.1007/s11920-013-0372-5 · Cited by 28
Masi, G., Milone, A., Stawinoga, A. E., Veltri, S., & Pisano, S. (2015) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000371 · Cited by 25
Kowatch, R. A., Scheffer, R. E., Monroe, E., Delgado, S. V., Altaye, M., & Lagory, D. (2015) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2014.0166 · Cited by 24
Treatment of Early-Age Mania: Outcomes for Partial and Nonresponders to Initial Treatment
Walkup, J. T., Wagner, K. D., Miller, L., Yenokyan, G., Luby, J. L., Joshi, P. T., Axelson, D., Robb, A. S., Salpekar, J. A., Wolf, D. V., et al. (2015) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2015.09.015 · Cited by 24
Sampogna, G., Janiri, D., Albert, U., Caraci, F., Martinotti, G., Serafini, G., Tortorella, A. A. V., Zuddas, A., Sani, G., & Fiorillo, A. (2022) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2022.2161895 · Cited by 25
Grant, B., & Salpekar, J. A. (2018) · Pediatric Drugs · doi:10.1007/s40272-018-0289-x · Cited by 24
de Pablo, G. S., Guinart, D., Cornblatt, B. A., Auther, A. M., Carrión, R. E., Carbon, M., Jiménez‐Fernández, S., Vernal, D. L., Walitza, S., Gerstenberg, M., et al. (2020) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2019.0138 · Cited by 23
Lithium Treatment in Children and Adolescents
Duffy, A., & Grof, P. (2018) · Pharmacopsychiatry · doi:10.1055/a-0575-4179 · Cited by 22
Twenty years of progress in paediatric psychopharmacology: accomplishments and unmet needs
Vitiello, B., & Davico, C. (2018) · Evidence Based Mental Health · doi:10.1136/ebmental-2018-300040 · Cited by 21
Nassan, M. M., Croarkin, P. E., Luby, J. L., Veldić, M., Joshi, P. T., McElroy, S. L., Post, R. M., Walkup, J. T., Cercy, K. M., Geske, J. R., et al. (2015) · Bipolar Disorders · doi:10.1111/bdi.12323 · Cited by 19
Safety considerations in the psychopharmacology of pediatric bipolar disorder
Sun, A. Y., Woods, S., Findling, R. L., & Stepanova, E. A. (2019) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2019.1637416 · Cited by 20
Clinical Characteristics Associated with Lithium Use among Adolescents with Bipolar Disorder
Ko, A., Swampillai, B., Timmins, V. H., Scavone, A., Collinger, K. A., & Goldstein, B. I. (2014) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2013.0120 · Cited by 19
Risk of Manic Switch Associated with Antidepressant Therapy in Pediatric Bipolar Depression
Bhowmik, D., Aparasu, R. R., Rajan, S. S., Sherer, J. T., Ochoa‐Perez, M., & Chen, H. (2014) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2014.0028 · Cited by 19
Clinical Manual of Child and Adolescent Psychopharmacology
(2017) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615371266 · Cited by 20
Baweja, R. K., & Waxmonsky, J. G. (2022) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2022.02.003 · Cited by 20
Amitai, M., Zivony, A., Kronenberg, S., Nagar, L., Saar, S., Sever, J. M., Apter, A., Shoval, G., Golubchik, P., Hermesh, H., et al. (2014) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2013.0046 · Cited by 18
Classifying Mood Symptom Trajectories in Adolescents With Bipolar Disorder
Weintraub, M. J., Schneck, C. D., Axelson, D., Birmaher, B. B., Kowatch, R. A., & Miklowitz, D. J. (2019) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2019.04.028 · Cited by 18
Mari, J. D. J., Dieckmann, L. H. J., Baldez, D. P., Haddad, M. F. C., da Silva, N. R., & Kapczinski, F. P. (2024) · BMJ Open · doi:10.1136/bmjopen-2024-087999 · Cited by 22
Pediatric Bipolar Disorder: Challenges in Diagnosis and Treatment
Wozniak, J. R., O’Connor, H., Iorini, M., & Ambrose, A. J. H. (2024) · Pediatric Drugs · doi:10.1007/s40272-024-00669-z · Cited by 22
Diagnosing bipolar disorder: Defining thresholds and setting boundaries
Malhi, G. S., & Berk, M. (2014) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867414536670 · Cited by 17
Psychotic symptoms and suicidal ideation in child and adolescent bipolar I disorder
Duffy, M. E., Gai, A. R., Rogers, M. L., Joiner, T. E., Luby, J. L., Joshi, P. T., Wagner, K. D., Emslie, G. J., Walkup, J. T., & Axelson, D. (2019) · Bipolar Disorders · doi:10.1111/bdi.12789 · Cited by 17
Pozzi, M., Pisano, S., Marano, G., Carnovale, C., Bravaccio, C., Rafaniello, C., Capuano, A., Rossi, F., Rizzo, R., Bernardini, R., et al. (2018) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2018.0092 · Cited by 17
Karpuz, D., Hallıoğlu, O., Toros, F., & Taşdelen, B. (2017) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2017.02.012 · Cited by 18
Mixed States in Early-Onset Bipolar Disorder
Saxena, K., Kurian, S. R., Saxena, J. E., Goldberg, A., Chen, E., & Simonetti, A. (2019) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2019.10.009 · Cited by 17
Quetiapine Monotherapy in Adolescents with Bipolar Disorder Comorbid with Conduct Disorder
Masi, G., Pisano, S., Pfanner, C., Milone, A., & Manfredi, A. (2013) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2013.0063 · Cited by 16
Tang, M. H., & Pinsky, E. G. (2015) · Pediatrics in Review · doi:10.1542/pir.36-2-52 · Cited by 16
Hobbs, E., Reed, R., Lorberg, B. A., Robb, A. S., & Dorfman, J. (2022) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2022.0035 · Cited by 15
Chen, H., Mehta, S., Aparasu, R. R., Patel, A. K., & Ochoa‐Perez, M. (2014) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3568 · Cited by 16
Badawy, A. A. ‐. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3191-9 · Cited by 15
Lithium in Child and Adolescent Bipolar Disorder
Rosen, M. S. (2017) · American Journal of Psychiatry Residents Journal · doi:10.1176/appi.ajp-rj.2017.120202 · Cited by 15
Bai, Y., Liu, T., Xu, A., Yang, H., & Gao, K. (2019) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2019.1632832 · Cited by 15
25 Years of the International Bipolar Collaborative Network (BCN)
Post, R. M., Altshuler, L. L., Kupka, R., McElroy, S. L., Frye, M. A., Grunze, H., Suppes, T. M., Keck, P. E., & Nolen, W. A. (2021) · International Journal of Bipolar Disorders · doi:10.1186/s40345-020-00218-w · Cited by 15
Windsor, R. B., Sierra, M., Zappitelli, M. W., & McDaniel, M. (2020) · Children · doi:10.3390/children7120268 · Cited by 16
Metadata
- Authors
- Geller, B.
- Affiliations
- Washington University in St. Louis (US)
- Corresponding author
- Geller, Barbara
- Venue
- Archives of General Psychiatry
- Publisher
- American Medical Association (AMA)
- Published
- 2012-05-01
- Volume
- 69
- Issue
- 5
- Pages
- 515
- ISSN
- 0003-990X (ISSN-L)
- PMC
- PMC3581342
- OpenAlex
- W2155569717
- Cited by
- 281
- References
- 38
- Citations by year
- 2026: 1 · 2025: 6 · 2024: 25 · 2023: 8 · 2022: 8 · 2021: 14 · 2020: 11 · 2019: 43 · 2018: 20 · 2017: 34 · 2016: 18 · 2015: 27 · 2014: 26 · 2013: 31 · 2012: 9
- FWCI
- 21.17
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Archives of General Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- Funders
- National Institute of Mental Health (U01MH064869, U01MH064868, U01MH064846, U01MH064850, U01MH064851, R01MH051481, U01MH064911, U01MH064887)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Social Sciences › Psychology › Clinical Psychology › Personality Disorders and Psychopathology
- Keywords
- bipolar I disorder, manic phase, mixed phase, children and adolescents, risperidone, lithium, divalproex sodium, initial treatment, rapid cycling, treatment response, adverse effects, mood stabilizers, antipsychotic drugs
- MeSH terms
- Adolescent, Bipolar Disorder, Child, Female, Humans, Male, Psychiatric Status Rating Scales, Valproic Acid, Lithium Carbonate, Treatment Outcome, Antimanic Agents, Risperidone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review